{
    "startDate": "2019-01-01",
    "endDate": "2019-06-30",
    "year": "2019",
    "quarter": "Q2",
    "symbol": "BIIB",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents, beginning of the period",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 1723400000.0
            },
            {
                "label": "Marketable securities",
                "concept": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
                "unit": "usd",
                "value": 1228800000.0
            },
            {
                "label": "Accounts receivable, net",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 1959600000.0
            },
            {
                "label": "Due from anti-CD20 therapeutic programs",
                "concept": "biib:DuefromantiCD20therapeuticprograms",
                "unit": "usd",
                "value": 557500000.0
            },
            {
                "label": "Components of inventories",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 776700000.0
            },
            {
                "label": "Assets held for sale",
                "concept": "AssetsHeldForSaleNotPartOfDisposalGroupCurrent",
                "unit": "usd",
                "value": 683400000.0
            },
            {
                "label": "Other current assets",
                "concept": "OtherAssetsCurrent",
                "unit": "usd",
                "value": 980400000.0
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 7909800000.0
            },
            {
                "label": "Marketable securities",
                "concept": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
                "unit": "usd",
                "value": 1309300000.0
            },
            {
                "label": "Property, plant and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 3077500000.0
            },
            {
                "label": "Operating lease assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 434400000.0
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 3681300000.0
            },
            {
                "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 5749200000.0
            },
            {
                "label": "Deferred tax asset",
                "concept": "DeferredTaxAssetsLiabilitiesNetNoncurrent",
                "unit": "usd",
                "value": 2820100000.0
            },
            {
                "label": "Investments and other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 1306000000.0
            },
            {
                "label": "Assets:",
                "concept": "Assets",
                "unit": "usd",
                "value": 26287600000.0
            },
            {
                "label": "Taxes payable",
                "concept": "TaxesPayableCurrent",
                "unit": "usd",
                "value": 427200000.0
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 377100000.0
            },
            {
                "label": "Liabilities held for sale",
                "concept": "DisposalGroupIncludingDiscontinuedOperationOtherLiabilities",
                "unit": "usd",
                "value": 88600000.0
            },
            {
                "label": "Total accrued expenses and other",
                "concept": "OtherLiabilitiesCurrent",
                "unit": "usd",
                "value": 2318000000.0
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 3210900000.0
            },
            {
                "label": "Notes payable",
                "concept": "LongTermDebt",
                "unit": "usd",
                "value": 5948500000.0
            },
            {
                "label": "Deferred tax liability",
                "concept": "DeferredTaxLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 2400600000.0
            },
            {
                "label": "Long-term operating lease liabilities",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 423000000.0
            },
            {
                "label": "Other long-term liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 1355800000.0
            },
            {
                "label": "Liabilities:",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 13338800000.0
            },
            {
                "label": "Commitments and contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, par value $0.001 per share",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, par value $0.0005 per share",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 100000.0
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -252900000.0
            },
            {
                "label": "Retained earnings",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": 16182800000.0
            },
            {
                "label": "Repurchase of common stock, at cost",
                "concept": "TreasuryStockValue",
                "unit": "usd",
                "value": 2977100000.0
            },
            {
                "label": "Beginning balance",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 12952900000.0
            },
            {
                "label": "Beginning balance",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": -4099999.9999999995
            },
            {
                "label": "Beginning balance",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 12948800000.0
            },
            {
                "label": "LIABILITIES AND EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 26287600000.0
            }
        ],
        "cf": [
            {
                "label": "Net income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 2902900000.0
            },
            {
                "label": "Depreciation, amortization and impairments",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 238100000.0
            },
            {
                "label": "Acquired in-process research and development",
                "concept": "ResearchAndDevelopmentInProcess",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Share-based Compensation Expense included in consolidated statements of income",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 98000000.0
            },
            {
                "label": "(Gain) loss on fair value remeasurement of contingent consideration",
                "concept": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
                "unit": "usd",
                "value": 8500000.0
            },
            {
                "label": "Loss on assets and liabilities held for sale",
                "concept": "IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsAttributableToParentBeforeIncomeTax",
                "unit": "usd",
                "value": -113200000.0
            },
            {
                "label": "Deferred income taxes",
                "concept": "DeferredIncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 71600000.0
            },
            {
                "label": "Unrealized (gain) loss on strategic investments",
                "concept": "IncreaseDecreaseInEquitySecuritiesFvNi",
                "unit": "usd",
                "value": 199200000.0
            },
            {
                "label": "Other",
                "concept": "OtherNoncashIncomeExpense",
                "unit": "usd",
                "value": -91100000.0
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": 2900000.0
            },
            {
                "label": "Inventory",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": -108700000.0
            },
            {
                "label": "Accrued expenses and other current liabilities",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": -216100000.0
            },
            {
                "label": "Income tax assets and liabilities",
                "concept": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
                "unit": "usd",
                "value": 306900000.0
            },
            {
                "label": "Other changes in operating assets and liabilities, net",
                "concept": "IncreaseDecreaseInOtherOperatingCapitalNet",
                "unit": "usd",
                "value": 80300000.0
            },
            {
                "label": "Cash flows from operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": 3423500000.0
            },
            {
                "label": "Proceeds from sales and maturities of marketable securities",
                "concept": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 3255800000.0
            },
            {
                "label": "Purchases of marketable securities",
                "concept": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
                "unit": "usd",
                "value": 2075100000.0
            },
            {
                "label": "Contingent consideration paid related to Fumapharm AG acquisition",
                "concept": "PaymentsToAcquireOtherProductiveAssets",
                "unit": "usd",
                "value": 300000000.0
            },
            {
                "label": "Acquisition of Nightstar Therapeutics plc, net of cash acquired",
                "concept": "PaymentsToAcquireBusinessesNetOfCashAcquired",
                "unit": "usd",
                "value": 744400000.0
            },
            {
                "label": "Purchases of property, plant and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 314000000.0
            },
            {
                "label": "Acquired in-process research and development",
                "concept": "PaymentsToAcquireInProcessResearchAndDevelopment",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Acquisitions of intangible assets",
                "concept": "PaymentsToAcquireIntangibleAssets",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Purchase of Ionis Pharmaceuticals, Inc. stock",
                "concept": "PaymentsToAcquireOtherInvestments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Proceeds from sales of strategic investments",
                "concept": "ProceedsFromSaleOfAvailableForSaleSecuritiesEquity",
                "unit": "usd",
                "value": 309700000.0
            },
            {
                "label": "Other",
                "concept": "PaymentsForProceedsFromOtherInvestingActivities",
                "unit": "usd",
                "value": 4000000.0
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": 128000000.0
            },
            {
                "label": "Purchases of treasury stock",
                "concept": "PaymentsForRepurchaseOfCommonStock",
                "unit": "usd",
                "value": 3057300000.0
            },
            {
                "label": "Payments related to issuance of stock for share-based compensation arrangements, net",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 23600000.0
            },
            {
                "label": "Net distribution to noncontrolling interest",
                "concept": "PaymentsToMinorityShareholders",
                "unit": "usd",
                "value": -4300000.0
            },
            {
                "label": "Other",
                "concept": "ProceedsFromPaymentsForOtherFinancingActivities",
                "unit": "usd",
                "value": 21600000.0
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": -3055000000.0
            },
            {
                "label": "Net increase (decrease) in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 496500000.0
            },
            {
                "label": "Effect of exchange rate changes on cash and cash equivalents",
                "concept": "EffectOfExchangeRateOnCashAndCashEquivalents",
                "unit": "usd",
                "value": 2300000.0
            }
        ],
        "ic": [
            {
                "label": "Numerator:",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 2902900000.0
            },
            {
                "label": "Unrealized gains (losses) on securities available for sale, net of tax",
                "concept": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
                "unit": "usd",
                "value": 10200000.0
            },
            {
                "label": "Unrealized gains (losses) on cash flow hedges, net of tax",
                "concept": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
                "unit": "usd",
                "value": -21000000.0
            },
            {
                "label": "Gains (losses) on net investment hedges",
                "concept": "TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 25700000.0
            },
            {
                "label": "Unrealized gains (losses) on pension benefit obligation, net of tax",
                "concept": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
                "unit": "usd",
                "value": -700000.0
            },
            {
                "label": "Currency translation adjustment",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": -28100000.0
            },
            {
                "label": "Other comprehensive income (loss), net of tax",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": -12500000.0
            },
            {
                "label": "Comprehensive income attributable to Biogen Inc.",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": 2890400000.0
            },
            {
                "label": "Comprehensive income (loss) attributable to noncontrolling interests, net of tax",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 400000.0
            },
            {
                "label": "Comprehensive income",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 2890000000.0
            },
            {
                "label": "Total revenues",
                "concept": "Revenues",
                "unit": "usd",
                "value": 7106500000.0
            },
            {
                "label": "Cost of sales, excluding amortization and impairment of acquired intangible assets",
                "concept": "CostOfGoodsAndServicesSold",
                "unit": "usd",
                "value": 1078300000.0
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
                "unit": "usd",
                "value": 1048500000.0
            },
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 1155300000.0
            },
            {
                "label": "Amortization and impairment of acquired intangible assets",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 138300000.0
            },
            {
                "label": "Collaboration profit (loss) sharing",
                "concept": "biib:Collaborationprofitlosssharing",
                "unit": "usd",
                "value": 121600000.0
            },
            {
                "label": "Loss on assets and liabilities held for sale",
                "concept": "DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown",
                "unit": "usd",
                "value": 113200000.0
            },
            {
                "label": "(Gain) loss on fair value remeasurement of contingent consideration",
                "concept": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
                "unit": "usd",
                "value": 8500000.0
            },
            {
                "label": "Restructuring charges",
                "concept": "RestructuringCharges",
                "unit": "usd",
                "value": 1200000.0
            },
            {
                "label": "Acquired in-process research and development",
                "concept": "ResearchAndDevelopmentInProcess",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Cost and expenses:",
                "concept": "CostsAndExpenses",
                "unit": "usd",
                "value": 3647900000.0
            },
            {
                "label": "Income from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": 3458600000.0
            },
            {
                "label": "Other income (expense), net",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": 159900000.0
            },
            {
                "label": "Income before income tax expense and equity in loss of investee, net of tax",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 3618500000.0
            },
            {
                "label": "Income tax expense",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 670600000.0
            },
            {
                "label": "Equity in loss of investee, net of tax",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -45000000.0
            },
            {
                "label": "Net income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 2902900000.0
            },
            {
                "label": "Net income (loss) attributable to noncontrolling interest, net of tax",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Basic earnings per share attributable to Biogen Inc.",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": 15.01
            },
            {
                "label": "Diluted earnings per share attributable to Biogen Inc.",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": 14.99
            },
            {
                "label": "Weighted average number of common shares outstanding",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 193400000.0
            },
            {
                "label": "Shares used in calculating diluted earnings per share",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 193700000.0
            }
        ]
    }
}